A citation-based method for searching scientific literature

Yun Luan, Sun Chao, Zhi-Ye Ju, Jue Wang, Xia Xue, Tong-Gang Qi, Guang-Hui Cheng, Feng Kong. Int Immunopharmacol 2015
Times Cited: 28







List of co-cited articles
98 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.
Marlene Rabinovitch, Christophe Guignabert, Marc Humbert, Mark R Nicolls. Circ Res 2014
431
25

Inflammatory cytokines in pulmonary hypertension.
Alexandra Groth, Bart Vrugt, Matthias Brock, Rudolf Speich, Silvia Ulrich, Lars C Huber. Respir Res 2014
97
17

Effects of baicalin on collagen Ι and collagen ΙΙΙ expression in pulmonary arteries of rats with hypoxic pulmonary hypertension.
Panpan Liu, Shuangquan Yan, Mayun Chen, Ali Chen, Dan Yao, Xiaomei Xu, Xueding Cai, Liangxing Wang, Xiaoying Huang. Int J Mol Med 2015
27
18

Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway.
Lin Zhang, Zhichen Pu, Junsong Wang, Zhifeng Zhang, Dongmei Hu, Junjie Wang. Int J Mol Sci 2014
33
17

Baicalin attenuates monocrotaline-induced pulmonary hypertension through bone morphogenetic protein signaling pathway.
Zhaohua Zhang, Luan Zhang, Chao Sun, Feng Kong, Jue Wang, Qian Xin, Wen Jiang, Kaili Li, Ou Chen, Yun Luan. Oncotarget 2017
8
62

Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.
Anna Csiszar, Nazar Labinskyy, Susan Olson, John T Pinto, Sachin Gupte, Joseph M Wu, Furong Hu, Praveen Ballabh, Andrej Podlutsky, Gyorgy Losonczy,[...]. Hypertension 2009
147
14

Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
Christophe Guignabert, Ly Tu, Morane Le Hiress, Nicolas Ricard, Caroline Sattler, Andrei Seferian, Alice Huertas, Marc Humbert, David Montani. Eur Respir Rev 2013
120
14

Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
Li Li, Chuanyu Wei, Il-Kwon Kim, Yvonne Janssen-Heininger, Sudhiranjan Gupta. Hypertension 2014
58
14

Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism.
Anthony Y H Woo, Christopher H K Cheng, Mary M Y Waye. Cardiovasc Res 2005
75
14

Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension.
Elaine Soon, Alan M Holmes, Carmen M Treacy, Natalie J Doughty, Laura Southgate, Rajiv D Machado, Richard C Trembath, Simon Jennings, Lucy Barker, Paul Nicklin,[...]. Circulation 2010
408
14



The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
Zhen Zeng, Yingchuan Li, Zhen Jiang, Chunsheng Wang, BingBing Li, Wei Jiang. Cardiovasc Ther 2010
15
20

Molecular pathogenesis of pulmonary arterial hypertension.
Marlene Rabinovitch. J Clin Invest 2012
417
10

TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Liam A Hurst, Benjamin J Dunmore, Lu Long, Alexi Crosby, Rafia Al-Lamki, John Deighton, Mark Southwood, Xudong Yang, Marko Z Nikolic, Blanca Herrera,[...]. Nat Commun 2017
80
10


Modern age pathology of pulmonary arterial hypertension.
Elvira Stacher, Brian B Graham, James M Hunt, Aneta Gandjeva, Steve D Groshong, Vallerie V McLaughlin, Marsha Jessup, William E Grizzle, Michaela A Aldred, Carlyne D Cool,[...]. Am J Respir Crit Care Med 2012
327
10

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
L Taraseviciene-Stewart, Y Kasahara, L Alger, P Hirth, G Mc Mahon , J Waltenberger, N F Voelkel, R M Tuder. FASEB J 2001
548
10

Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Ai-Wu Wang, Lina Song, Jie Miao, Hong-Xia Wang, Cui Tian, Xue Jiang, Qiu-Yue Han, Liqing Yu, Ying Liu, Jie Du,[...]. Am J Hypertens 2015
31
10

Baicalin administration attenuates hyperglycemia-induced malformation of cardiovascular system.
Guang Wang, Jianxin Liang, Lin-Rui Gao, Zhen-Peng Si, Xiao-Tan Zhang, Guo Liang, Yu Yan, Ke Li, Xin Cheng, Yongping Bao,[...]. Cell Death Dis 2018
21
14

The flavonoid quercetin reverses pulmonary hypertension in rats.
Daniel Morales-Cano, Carmen Menendez, Enrique Moreno, Javier Moral-Sanz, Bianca Barreira, Pilar Galindo, Rachele Pandolfi, Rosario Jimenez, Laura Moreno, Angel Cogolludo,[...]. PLoS One 2014
49
10

Pulmonary arterial hypertension: pathogenesis and clinical management.
Thenappan Thenappan, Mark L Ormiston, John J Ryan, Stephen L Archer. BMJ 2018
205
10



PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.
Hyun Ae Lim, Eun Kyeong Lee, Ji Min Kim, Min Hi Park, Dae Hyun Kim, Yeon Ja Choi, Young Mi Ha, Jeong-Hyun Yoon, Jae Sue Choi, Byung Pal Yu,[...]. Biogerontology 2012
47
7

Protective effects of baicalin against ischemia/reperfusion injury in rat liver.
Seok-Joo Kim, Young-Joo Moon, Sun-Mee Lee. J Nat Prod 2010
34
7

Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells.
Shou-jin Dong, Yun-qing Zhong, Wen-ting Lu, Guan-hong Li, Hong-li Jiang, Bing Mao. Inflammation 2015
40
7

Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Jing-Yuan Wan, Xia Gong, Li Zhang, Hong-Zhong Li, Yu-Fan Zhou, Qi-Xin Zhou. Eur J Pharmacol 2008
67
7

Baicalin induces apoptosis of gallbladder carcinoma cells in vitro via a mitochondrial-mediated pathway and suppresses tumor growth in vivo.
Yi-Jun Shu, Run-Fa Bao, Xiang-Song Wu, Hao Weng, Qian Ding, Yang Cao, Mao-Lan Li, Jia-Sheng Mu, Wen-Guang Wu, Qi-Chen Ding,[...]. Anticancer Agents Med Chem 2014
18
11


New treatment strategies for pulmonary arterial hypertension: hopes or hypes?
Nazzareno Galiè, Alessandra Manes. J Am Coll Cardiol 2013
31
7

Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats.
L C Price, D Montani, C Tcherakian, P Dorfmüller, R Souza, N Gambaryan, M-C Chaumais, D M Shao, G Simonneau, L S Howard,[...]. Eur Respir J 2011
63
7

Targeted therapies in pulmonary arterial hypertension.
David Montani, Marie-Camille Chaumais, Christophe Guignabert, Sven Günther, Barbara Girerd, Xavier Jaïs, Vincent Algalarrondo, Laura C Price, Laurent Savale, Olivier Sitbon,[...]. Pharmacol Ther 2014
112
7

The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
You-Fei Fan, Rui Zhang, Xin Jiang, Li Wen, Dan-Chen Wu, Dong Liu, Ping Yuan, Yu-Lin Wang, Zhi-Cheng Jing. Cardiovasc Res 2013
41
7


Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension.
Madhukar B Kolli, Nandini D P K Manne, Radhakrishna Para, Siva K Nalabotu, Geeta Nandyala, Tolou Shokuhfar, Kun He, Azhang Hamlekhan, Jane Y Ma, Paulette S Wehner,[...]. Biomaterials 2014
23
8


Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension.
Peter Dorfmüller, Marie-Camille Chaumais, Maria Giannakouli, Ingrid Durand-Gasselin, Nicolas Raymond, Elie Fadel, Olaf Mercier, Frédéric Charlotte, David Montani, Gérald Simonneau,[...]. Respir Res 2011
55
7


The Restorative Effects of Eucommia ulmoides Oliver Leaf Extract on Vascular Function in Spontaneously Hypertensive Rats.
Shingo Hosoo, Masahiro Koyama, Mai Kato, Tetsuya Hirata, Yasuyo Yamaguchi, Hiroo Yamasaki, Atsunori Wada, Keiji Wada, Sansei Nishibe, Kozo Nakamura. Molecules 2015
21
9

The structural factor of hypertension: large and small artery alterations.
Stéphane Laurent, Pierre Boutouyrie. Circ Res 2015
207
7

Isorhynchophylline protects against pulmonary arterial hypertension and suppresses PASMCs proliferation.
Haipeng Guo, Xin Zhang, Yuqian Cui, Wei Deng, Dachun Xu, Hui Han, Hao Wang, Yuguo Chen, Yu Li, Dawei Wu. Biochem Biophys Res Commun 2014
18
11

Prescription pattern of Chinese herbal products for hypertension in Taiwan: a population-based study.
Der-Shiang Tsai, Yuan-Shiun Chang, Tsai-Chung Li, Wen-Huang Peng. J Ethnopharmacol 2014
18
11

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
H L Hillege, A R Girbes, P J de Kam, F Boomsma, D de Zeeuw, A Charlesworth, J R Hampton, D J van Veldhuisen. Circulation 2000
733
7


Treatment of pulmonary arterial hypertension.
Marc Humbert, Olivier Sitbon, Gérald Simonneau. N Engl J Med 2004
7

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats.
Marie-Camille Chaumais, Benoît Ranchoux, David Montani, Peter Dorfmüller, Ly Tu, Florence Lecerf, Nicolas Raymond, Christophe Guignabert, Laura Price, Gérald Simonneau,[...]. Respir Res 2014
35
7

A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.
Hirofumi Sawada, Yoshihide Mitani, Junko Maruyama, Bao Hua Jiang, Yukiko Ikeyama, Francis A Dida, Hatsumi Yamamoto, Kyoko Imanaka-Yoshida, Hideto Shimpo, Akira Mizoguchi,[...]. Chest 2007
66
7

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
Anton Vonk-Noordegraaf, François Haddad, Kelly M Chin, Paul R Forfia, Steven M Kawut, Joost Lumens, Robert Naeije, John Newman, Ronald J Oudiz, Steve Provencher,[...]. J Am Coll Cardiol 2013
506
7

The pathogenesis of idiopathic pulmonary fibrosis.
William R Coward, Gauri Saini, Gisli Jenkins. Ther Adv Respir Dis 2010
175
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.